AI Article Synopsis
- The first monkeypox case in Korea was reported in June 2022, leading to public questions about vaccination due to recent COVID-19 experiences.
- A ring vaccination strategy, focusing on high-risk groups, is more suitable than mass vaccination with smallpox vaccines for the current monkeypox outbreak.
- Proper identification of target groups for vaccination should consider risk-benefit analysis and be updated based on local epidemiological data and current understanding of monkeypox transmission and severity.
Article Abstract
In June 2022, the first monkeypox case was reported as imported into Korea. The general public asked whether they should get vaccinated against monkeypox because of the recent COVID-19 vaccination experience. As of the current monkeypox outbreak situation, a ring vaccination strategy for the high-risk group is more appropriate than the mass population vaccination with smallpox vaccines. Therefore, identifying the proper target group by available vaccines based on the risk and benefit analysis is a key issue of the vaccination program. In addition, the target group should be reviewed by the epidemiological situation of the jurisdiction along with the updated evidence of the monkeypox virus on transmission dynamics, severity, and fatality.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313979 | PMC |
| http://dx.doi.org/10.3346/jkms.2022.37.e239 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!